Silence Therapeutics plc

NASDAQ:SLN

Biotechnology

Healthcare
$19.80 +2.81%

+$0.19 today

Market cap
$935.23M
Beta
1.48
P/E (TTM)
-3.9
EPS (TTM)
-$1.80
52W Low $4.19High $8.40

Volume 1.21M

Average 0.31M

Price history

Silence Therapeutics plc SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+193.33%

Period high

$19.83

Period low

$4.30

Latest

$19.80

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 13, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
DEFA14ANov 12, 2026Nov 12, 2026
SC 13G/ANov 12, 2026Nov 12, 2026
SC 13GNov 5, 2026Nov 5, 2026
DEFA14AOct 19, 2026Oct 19, 2026
DEFA14AOct 19, 2026Oct 19, 2026
8-KOct 19, 2026Oct 19, 2026
SC 13GOct 13, 2026Oct 13, 2026
SC 13G/AOct 13, 2026Oct 13, 2026
SC 13D/AAug 13, 2026Aug 13, 2026
4Aug 13, 2026Aug 13, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
424B5Aug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026

Competitors

Who does Silence Therapeutics plc compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about SLN's filings, answered from its disclosures.

What is the latest SLN filing?

The latest filing shown is 10-Q dated Nov 13, 2026.

How many recent filings does SLN have?

Intrinsic Alpha currently shows 20 recent filings for SLN.